XML 54 R30.htm IDEA: XBRL DOCUMENT v3.22.1
SEGMENTED INFORMATION
 12 Months Ended
Dec. 31, 2021
SEGMENTED INFORMATION  
Segmented Information

25. SEGMENTED INFORMATION

 

The Company is engaged in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products through its Colombia Cosechemos subsidiary. The Company’s other businesses are run through its other Colombia and United States subsidiaries. Management has defined the reportable segments of the Company based on this internal business unit reporting, which is by major product line, and aggregates similar businesses into the Consumer Products segment below. The Corporate segment reflects balances and expenses that do not directly influence business unit operations and includes the Company’s long-term investments. The Corporate segment revenue includes the license of intellectual property.

 

The following tables show information regarding the Company’s segments for the years ended December 31, 2021 and 2020. The 2020 amounts were restated to conform to the Company’s current 2021 reportable segments determination.

 

In 2021, the Company had sales to a single customer exceeding 10% of its consolidated revenue. Sales to this customer were $1.3 million and were part of the Beverage and Food reportable segment.

 

 

 Cannabis growth and derivative production

 

 

 Consumer products

 

 

 Pharmaceuticals and nutraceuticals

 

 

 Beverage and food

 

 

 Corporate

 

 

 Total

 

Thousands of United States dollars

 

 $

 

 

 $

 

 

 $  

 

 

$

 

 

$   

 

 

$

 

For the year ended December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$3

 

 

$2,620

 

 

$2,342

 

 

$3,577

 

 

$438

 

 

$8,980

 

Gross profit

 

 

(85)

 

 

865

 

 

 

802

 

 

 

347

 

 

 

424

 

 

 

2,353

 

Net loss

 

 

(1,075)

 

 

(960)

 

 

(70)

 

 

(281)

 

 

(18,975)

 

 

(21,361)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the year ended December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$ 

-

 

 

$ 

89

 

 

$ 

-

 

 

$ 

-

 

 

$ 

17

 

 

$ 

106

 

Gross profit

 

 

-

 

 

 

66

 

 

 

-

 

 

 

-

 

 

 

5

 

 

 

71

 

Net loss

 

 

(612)

 

 

(506)

 

 

-

 

 

 

-

 

 

 

(13,216)

 

 

(14,334)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

        

 

 

 

 

 

 

 

 

 

 

 

Colombia

 

 

United States

 

 

Canada

 

 

Total

 

Thousands of United States dollars

 

 $

 

 

 $

 

 

 $

 

 

$

 

Non-current assets at December 31, 2021

 

$ 

4,042

 

 

$ 

29,650

 

 

$ 

3,844

 

 

$

37,536

 

Total liabilities at December 31, 2021

 

 

2,359

 

 

 

3,106

 

 

 

3,073

 

 

 

8,538

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-current assets at December 31, 2020

 

$

1,818

 

 

$ 

-

 

 

$ 

-

 

 

$ 

1,818

 

Total liabilities at December 31, 2020

 

 

1,922

 

 

 

12

 

 

 

1,268

 

 

 

3,202

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$

6,919

 

 

$ 

1,681

 

 

$ 

380

 

 

$ 

8,980

 

Gross profit

 

 

1,419

 

 

 

554

 

 

 

380

 

 

 

2,353

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Year ended December 31, 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$

75

 

 

$ 

31

 

 

$ 

-

 

 

$ 

106

 

Gross profit

 

 

40

 

 

 

31

 

 

 

-

 

 

 

71